JANX JANUX THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Public Offering Janux Therapeutics, Inc. entered into an underwriting agreement for a public offering of its common stock and pre-funded warrants, with an estimated gross proceeds of approximately $296.5 million.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC